Samuel Bieligk, MD, FACS
Southwestern Regional Medical Center
"I’m excited to lead a program at the hospital for hyperthermic intraperitoneal chemotherapy, or HIPEC. It provides a new, highly innovative treatment option to people who have colorectal, appendiceal, ovarian, gastric or primary peritoneal cancer."
- Samuel Corwin Bieligk
- University of Oklahoma College of Medicine, Oklahoma City
Internship / Residency
- General Surgery - Tulane University School of Medicine, New Orleans
- Research Fellow - Tulane University School of Medicine
- Surgical Oncology - Memorial Sloan-Kettering Cancer Center, New York
- Diplomate, American Board of Surgery
Practicing Since: 1997
Dr. Samuel Bieligk is an experienced surgical oncologist who is committed to helping patients with cancer and improving their quality of life. He is a Diplomate of the American Board of Surgery.
The opportunity to be a part of a national organization focused on cancer care drew Dr. Bieligk to Cancer Treatment Centers of America (CTCA) in Tulsa, Oklahoma in September 2011.
He was also excited about developing a program at the hospital for hyperthermic intraperitoneal chemotherapy. "HIPEC is specifically designed to treat patients who have a spread of the tumor within their abdomen called carcinomatosis,” he explains.
In addition to the HIPEC procedure and cytoreductive surgery to remove tumors in the abdomen, Dr. Bieligk regularly performs laparoscopic colectomies, liver resections, splenectomies, adrenalectomies, oophorectomies and other sophisticated procedures.
“I utilize laparoscopy to evaluate patients’ intra-abdominal disease, which may be difficult to assess by CT or PET scans. Furthermore, laparoscopy enables me to limit the amount of incisions needed to perform some procedures," he says. "In turn, patients may experience less trauma, scarring and pain, and a shorter recovery."
After receiving a bachelor’s degree in chemical engineering from the University of Oklahoma, Dr. Bieligk earned a medical degree from the university’s medical school. He went on to complete a general surgery residency and a research fellowship at Tulane University School of Medicine in New Orleans, and a surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York City.
Prior to joining CTCA, Dr. Bieligk served as Medical Director of Surgical Oncology at St. John’s Regional Medical Center in Joplin, Missouri. He has also served as an attending surgeon at hospitals in Maryland, and as an assistant professor in the departments of surgery at the University of Maryland School of Medicine in Baltimore and the University of Texas Southwestern Medical Center at Dallas.
Dr. Bieligk has held several appointments on various hospital surgical and cancer committees. Additionally, he has served as the Vice President of the Southwest Missouri Chapter of the American College of Surgeons. Dr. Bieligk has also been published in such leading clinical publications as the Journal of the American College of Surgeons, Annals of Surgical Oncology and the Journal of Surgical Oncology. He has contributed to multiple research projects and clinical research protocols, and presented at numerous clinical conferences across the country.
Dr. Bieligk is a member of the American College of Surgeons, Society of Surgical Oncology and American Medical Association.
Dr. Bieligk, his wife and their son and three daughters are survivors of the 2011 tornado in Joplin, Missouri. He says they are thrilled to make Oklahoma their new home. Dr. Bieligk’s wife Karen is from Oklahoma and has family that lives in Oklahoma City. He is a huge Oklahoma Sooner fan, and, when not working, enjoys spending time with his family.